Press news Biocartis Group NV: Biocartis Announces Partnership with Endpoint Health to Develop Novel Companion Diagnostic in Critical Illness

NEXT STORY
Everest Medicines Announces First Patient Dosed in its Phase 2b Registration Clinical Trial of Trodelvy™ (sacituzumab govitecan) for Metastatic Triple-Negative Breast Cancer in China
PREV STORY
Valneva Reports Nine Month Results Marked by Further Major Corporate Achievements
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Symphogen publishes discovery and pre-clinical data on first chicken-derived antibody to enter human clinical trials

author_avatar
NASDAQ Market News

Sabin Vaccine Institute Names Richard Adegbola and Yacine Djibo to Board of Trustees

author_avatar
NASDAQ Market News

Amarin Announces REDUCE-IT Cardiovascular Outcomes Study Final Patient Visits to Commence in March 2018

BEDMINSTER, N.J., and DUBLIN, Ireland, Dec. 19, 2017 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), ...

author_avatar
NASDAQ Market News